Heterociclos de interés biológico y terapéutico
Instituto de Química Médica
Madrid, EspañaPublications in collaboration with researchers from Instituto de Química Médica (9)
2022
-
Curcumin-piperlongumine hybrids with a multitarget profile elicit neuroprotection in in vitro models of oxidative stress and hyperphosphorylation
Antioxidants, Vol. 11, Núm. 1
-
Enantioselective Synthesis and Pharmacological Evaluation of Aza‐CGP37157–Lipoic Acid Hybrids for the Treatment of Alzheimer’s Disease
Antioxidants, Vol. 11, Núm. 1
2021
-
Bisavenathramide analogues as nrf2 inductors and neuroprotectors in in vitro models of oxidative stress and hyperphosphorylation
Antioxidants, Vol. 10, Núm. 6
-
Enhanced stability and bioactivity of natural anticancer topoisomerase i inhibitors through cyclodextrin complexation
Pharmaceutics, Vol. 13, Núm. 10
2017
-
Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity
European Journal of Medicinal Chemistry, Vol. 141, pp. 138-148
2013
-
A fluorescent styrylquinoline with combined therapeutic and diagnostic activities against Alzheimer's and prion diseases
ACS Medicinal Chemistry Letters, Vol. 4, Núm. 2, pp. 225-229
1990
-
Synthesis and structural study of dichloro di-2-benzothiazolylphenylmethanol Zinc(II)
Inorganica Chimica Acta, Vol. 174, Núm. 2, pp. 169-173
1989
-
Photo‐Oxidation of Some DI‐2‐Benzothiazolymethane Derivatives
Bulletin des Sociétés Chimiques Belges, Vol. 98, Núm. 7, pp. 497-501
-
Tautomerism of bis(2-benzothiazolyl)arylmethanes
Heterocycles, Vol. 29, Núm. 1, pp. 165-180